In the Adaptive COVID-19 Treatment Trial involving more than 1,000 patients testing the efficacy of the antiviral remdesivir, only 20% of participants are Black and 23% are Hispanic or Native American.
from WebMD Health https://www.webmd.com/lung/news/20200817/covid-19-clinical-trials-lack-diversity-researchers-say?src=RSS_PUBLIC
0 Comments:
Post a Comment